Clinical Trial

GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Post-Market Clinical Follow-Up (PMCF) Observational Registry (RE-PROVE)

Recruiting
View on ClinicalTrials.gov →
Summary
Collect real-world post-market clinical follow-up data on subjects treated with the Reduced Profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (Reduced Profile VBX Stent Graft-BXB)
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-03
Trial Details
NCT Number NCT07279649
Lead Sponsor W.L.Gore & Associates
Conditions Aorto-iliac Occlusive Disease (AIOD), Visceral Artery Occlusive Disease (VAOD), Isolated Artery Aneurysms (IAA), Trauma or Iatrogenic Vessel Injury
Enrollment 240 participants
Start Date 2026-05-08
Primary Completion 2031-01 (estimated)
Study Completion 2031-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-02